Huahui Health
Clinical trials sponsored by Huahui Health, explained in plain language.
-
New hope for advanced liver cancer: experimental drug HH-009 enters trials
Disease control Not yet recruitingThis study tests an experimental drug called HH-009 in about 30 adults with advanced liver cancer that has not responded to previous treatments. Participants receive one of two doses of HH-009 every three weeks. The goal is to see if the drug can slow cancer growth and how safe i…
Phase: PHASE1, PHASE2 • Sponsor: Huahui Health • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
New drug shows promise against rare liver infection
Disease control Not yet recruitingThis study tests a new medicine called libevitug for people with chronic hepatitis D, a serious liver infection. About 160 adults will receive either a low or high dose of the drug every two weeks for 96 weeks, or wait 48 weeks before starting treatment. The goal is to see if the…
Phase: PHASE3 • Sponsor: Huahui Health • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC